Cleared Traditional

K843343 - MEDICA IIF-ANTI-THYROID ANTIBODY TEST

K843343 is an FDA 510(k) clearance for MEDICA IIF-ANTI-THYROID ANTIBODY TEST, manufactured by Medical Diagnostics, Ca.. The device is a Class 2 Immunology device with product code JZO cleared through the Traditional 510(k) pathway after a 56-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1984
Decision
56d
Days
Class 2
Risk

K843343 is an FDA 510(k) clearance for the MEDICA IIF-ANTI-THYROID ANTIBODY TEST. Classified as System, Test, Thyroid Autoantibody (product code JZO), Class II - Special Controls.

Submitted by Medical Diagnostics, Ca. (Calsbad, US). The FDA issued a Cleared decision on October 22, 1984 after a review of 56 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5870 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K843343

510(k) Number K843343 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 27, 1984
Decision Date October 22, 1984
Days to Decision 56 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
49d faster than avg
Panel avg: 105d · This submission: 56d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JZO Device Classification - Class 2, Special Controls

Product Code JZO System, Test, Thyroid Autoantibody
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5870
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - JZO System, Test, Thyroid Autoantibody

All 91
Devices cleared under the same product code (JZO) and FDA review panel - the closest regulatory comparables to K843343.
SERA-TEK MICROSOMAL ANTIBODY TEST
K865053 · Miles Laboratories, Inc. · Feb 1987
125-I TSH RECEPTOR ANTIBODY KIT
K863006 · Cronus · Sep 1986
TSH RECEPTOR ANTIBODY KIT 125I TSH
K841580 · Clinetics Corp. · Oct 1984
CORDIA TG
K821489 · Cordis Corp. · Jun 1982
ANTITHYROID ANTIBODY IMMUNOFLUORESCENT
K810982 · Immuno-Products Industries · May 1981
AGGLUTINOTEST-THYROGLOBULIN
K791458 · Volu Sol Medical Industries · Dec 1979